IGM Biosciences, Inc.
MULTIMERIC GITR BINDING MOLECULES AND USES THEREOF
Last updated:
Abstract:
This disclosure provides dimeric, pentameric, and hexameric GITR agonist binding molecules and methods of using such binding molecules to induce anti-tumor immunity.
Status:
Application
Type:
Utility
Filling date:
20 Jul 2017
Issue date:
31 Oct 2019